Evidence map›Paper›PMID 40574869›Full record

ReviewClinical and translational radiation oncology2025

Head and neck and skin (HNS) GEC-ESTRO and BRAPHYQS working groups joint critical review of the use of Rhenium-188 in dermato-oncology.

Sergio Lozares, Paula Tur, Facundo Ballester, Ralph Alexander Bundschuh, Víctor González-Pérez, Ramin Jaberi, Javier Vijande, Renate Walter, Åsa Carlsson Tedgren, Luca Tagliaferri and 2 more

Abstract readReview
In one paragraph

Review in Clinical and translational radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sergio LozaresPhysics and Radiation Protection Department, Miguel Servet University Hospital, Zaragoza, Spain.
Paula TurFaculty of Science, Agriculture and Engineering, Newcastle University, Newcastle-upon-Tyne, UK.
Facundo BallesterDepartamento de Física Atómica, Molecular y Nuclear, Universitat de Valencia (UV), Burjassot, Spain.
Ralph Alexander BundschuhNuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Víctor González-PérezDepartment of Medical Physics, Fundación Instituto Valenciano de Oncología (F.I.V.O.), Beltran Baguena 8, 46009 Valencia, Spain.
Ramin JaberiRadiation Oncology Research Centre (RORC), Cancer Institute, Tehran University of Medical Sciences, Keshavarz Blvd, Qods Street, 1417863181 Tehran, Iran.
Javier VijandeDepartamento de Física Atómica, Molecular y Nuclear, Universitat de Valencia (UV), Burjassot, Spain.
Renate WalterDepartment of Medical Physics, Universitätsklinikum Augsburg, Stenglinstr 2, 86156 Augsburg, Germany.
Åsa Carlsson TedgrenRadiation Physics, Department of Medicine and Health (IMH), Linköping University, Linköping, Sweden.
Luca TagliaferriUOC Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.
Frank-André SiebertClinic of Radiotherapy, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, Haus L, 24105 Kiel, Germany.
Agata RembielakDepartment of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-melanoma skin cancers are increasing globally, prompting the need for innovative, non-invasive treatment approaches. Radioactive rhenium (

Indexed as

BrachytherapyClinical outcomesDermato-oncologyDosimetryMultidisciplinary treatmentNon-melanoma skin cancerOpen-source radiotherapyRhenium-188

Identifiers

PMID40574869
PMCPMC12197883

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.